These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2804345)

  • 21. Molecular recognition in the activation of human blood coagulation factor X.
    Chattopadhyay A; Fair DS
    J Biol Chem; 1989 Jul; 264(19):11035-43. PubMed ID: 2500433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Blood coagulation disorders caused by abnormal blood coagulation factors].
    Fiedler H
    Z Arztl Fortbild (Jena); 1972 Jul; 66(13):692-8. PubMed ID: 4636972
    [No Abstract]   [Full Text] [Related]  

  • 23. Anticoagulant and antithrombotic properties of a gamma-carboxyglutamic acid-rich peptide derived from the light chain of blood coagulation factor X.
    Nawroth PP; Kisiel W; Stern DM
    Thromb Res; 1986 Dec; 44(5):625-37. PubMed ID: 3810564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The activation of coagulation factor X. Identity of cleavage sites in the alternative activation pathways and characterization of the COOH-terminal peptide.
    Jesty J; Spencer AK; Nakashima Y; Nemerson Y; Konigsberg W
    J Biol Chem; 1975 Jun; 250(12):4497-504. PubMed ID: 1141218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Factors V, VII, and X--interpretation of test results].
    Fukutake K; Ukita M
    Nihon Rinsho; 1973; 31():1734-9. PubMed ID: 4582277
    [No Abstract]   [Full Text] [Related]  

  • 26. Factor IX is activated in vivo by the tissue factor mechanism.
    Bauer KA; Kass BL; ten Cate H; Hawiger JJ; Rosenberg RD
    Blood; 1990 Aug; 76(4):731-6. PubMed ID: 2383653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action.
    Broze GJ; Warren LA; Novotny WF; Higuchi DA; Girard JJ; Miletich JP
    Blood; 1988 Feb; 71(2):335-43. PubMed ID: 3422166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mapping the active sites of bovine thrombin, factor IXa, factor Xa, factor XIa, factor XIIa, plasma kallikrein, and trypsin with amino acid and peptide thioesters: development of new sensitive substrates.
    McRae BJ; Kurachi K; Heimark RL; Fujikawa K; Davie EW; Powers JC
    Biochemistry; 1981 Dec; 20(25):7196-206. PubMed ID: 6976185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of Mac-1 (CD11b/CD18)-bound factor X by released cathepsin G defines an alternative pathway of leucocyte initiation of coagulation.
    Plescia J; Altieri DC
    Biochem J; 1996 Nov; 319 ( Pt 3)(Pt 3):873-9. PubMed ID: 8920993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The procoagulant activity of granulocytes.
    Saba HI; Herion JC; Walker RI; Roberts HR
    Proc Soc Exp Biol Med; 1973 Feb; 142(2):614-20. PubMed ID: 4689394
    [No Abstract]   [Full Text] [Related]  

  • 31. Role of the activation peptide domain in human factor X activation by the extrinsic Xase complex.
    Baugh RJ; Krishnaswamy S
    J Biol Chem; 1996 Jul; 271(27):16126-34. PubMed ID: 8663201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prothrombin fragment 1 X 2 X 3, a major product of prothrombin activation in human plasma.
    Rabiet MJ; Blashill A; Furie B; Furie BC
    J Biol Chem; 1986 Oct; 261(28):13210-5. PubMed ID: 3759958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of factor VII in the intrinsic pathway: a brief review.
    Prydz H
    Haemostasis; 1983; 13(3):156-60. PubMed ID: 6350120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The anticoagulant mechanism of action of heparin in contact-activated plasma: inhibition of factor X activation.
    McNeely TB; Griffith MJ
    Blood; 1985 May; 65(5):1226-31. PubMed ID: 3995171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors IXa and Xa play distinct roles in tissue factor-dependent initiation of coagulation.
    Hoffman M; Monroe DM; Oliver JA; Roberts HR
    Blood; 1995 Sep; 86(5):1794-801. PubMed ID: 7655009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A coagulation pathway on bovine aortic segments leading to generation of Factor Xa and thrombin.
    Stern DM; Nawroth PP; Kisiel W; Handley D; Drillings M; Bartos J
    J Clin Invest; 1984 Dec; 74(6):1910-21. PubMed ID: 6439737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reactivity of bovine blood coagulation factor IXa beta, factor Xa beta, and factor XIa toward fluorogenic peptides containing the activation site sequences of bovine factor IX and factor X.
    Castillo MJ; Kurachi K; Nishino N; Ohkubo I; Powers JC
    Biochemistry; 1983 Mar; 22(5):1021-9. PubMed ID: 6601494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of coagulation after administration of tumor necrosis factor to normal subjects.
    van der Poll T; Büller HR; ten Cate H; Wortel CH; Bauer KA; van Deventer SJ; Hack CE; Sauerwein HP; Rosenberg RD; ten Cate JW
    N Engl J Med; 1990 Jun; 322(23):1622-7. PubMed ID: 2188129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aptamer ARC19499 mediates a procoagulant hemostatic effect by inhibiting tissue factor pathway inhibitor.
    Waters EK; Genga RM; Schwartz MC; Nelson JA; Schaub RG; Olson KA; Kurz JC; McGinness KE
    Blood; 2011 May; 117(20):5514-22. PubMed ID: 21389323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of molecular sites on factor VII which mediate its assembly and function in the extrinsic pathway activation complex.
    Kumar A; Blumenthal DK; Fair DS
    J Biol Chem; 1991 Jan; 266(2):915-21. PubMed ID: 1985971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.